Browsing by Author "Sacramento, Carolina Q."
Now showing items 11-30 of 42
-
Chemistry and anti-herpes simplex virus type 1 evaluation of 4-substituted-1H-1,2,3-triazole-nitroxyl-linked hybrids
Cunha, Anna C. et al. | Date Issued: 2021 -
Combination of antiviral drugs inhibits SARS-CoV- 2 polymerase and exonuclease and demonstrates COVID-19 therapeutic potential in viral cell culture
Wang, Xuanting et al. | Date Issued: 2022 -
Combination of Antiviral Drugs to Inhibit SARS-CoV-2 Polymerase and Exonuclease as Potential COVID-19 Therapeutics
Wang, Xuanting et al. | Date Issued: 2021 -
Commercially Available Flavonols Are Better SARS-CoV-2 Inhibitors than Isoflavone and Flavones
Chaves, Otávio Augusto et al. | Date Issued: 2022 -
Computational and Experimental Approaches Identify Beta-Blockers as Potential SARS-CoV‑2 Spike Inhibitors
Phul, Ana C. et al. | Date Issued: 2022 -
Dengue induces iNOS expression and nitric oxide synthesis in platelets through IL-1R
Pinheiro, Mariana Brandi Mendonça et al. | Date Issued: 2022 -
Design, synthesis, and antiviral activity of new 1H-1,2,3-triazole nucleoside ribavirin analogs
Ferreira, Maria de Lourdes G. et al. | Date Issued: 2014 -
Detection of the Influenza A(H1N1)pdm09 Virus Carrying the K-15E, P83S and Q293H Mutations in Patients Who Have Undergone Bone Marrow Transplant
Mesquita, Milene et al. | Date Issued: 2014 -
Fluorine Atoms on C6H5-Corrole Affect the Interaction with Mpro and PLpro Proteases of SARS-CoV-2: Molecular Docking and 2D-QSAR Approaches
Chaves, Otávio Augusto et al. | Date Issued: 2022 -
Genetic evidence and host immune response in persons reinfected with SARS-CoV-2, Brazil
Fintelman-Rodrigues, Natalia et al. | Date Issued: 2021 -
HIV-1 and Its gp120 Inhibits the Influenza A(H1N1)pdm09 Life Cycle in an IFITM3-Dependent Fashion
Mesquita, Milene et al. | Date Issued: 2014 -
Human endogenous retrovirus K in the respiratory tract is associated with COVID‑19 physiopathology
Temerozo, Jairo R. et al. | Date Issued: 2022 -
In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19
Sacramento, Carolina Q. et al. | Date Issued: 2021 -
Influenza virus RNA polymerase may be activated inside the virion
Sacramento, Carolina Q. et al. | Date Issued: 2018 -
Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators
Dias, Suelen da Silva Gomes et al. | Date Issued: 2020 -
Non-permissive SARS-CoV-2 infection in human neurospheres
Pedrosa, Carolina da S.G. et al. | Date Issued: 2021 -
Non-permissive SARS-CoV-2 infection in human neurospheres (preprint)
Pedrosa, Carolina da Silva Gouveia et al. | Date Issued: 2021 -
Platelet-monocyte interaction amplifies thromboinflammation through tissue factor signaling in COVID-19
Hottz, Eugenio D. et al. | Date Issued: 2022 -
Polyclonal F(ab’)2 fragments of equine antibodies raised against the spike protein neutralize SARSCoV- 2 variants with high potency
Cunha, Luis Eduardo R. et al. | Date Issued: 2021 -
Preclinical development of kinetin as a safe error-prone SARS-CoV-2 antiviral able to attenuate virus-induced inflammation
Souza, Thiago Moreno L. et al. | Date Issued: 2023O artigo trata do desenvolvimento de um antiviral de uso oral contra a Covid-19. A substância, batizada de MB-905, foi purificada a partir da cinetina e demonstrou-se eficaz para inibir a replicação do Sars-CoV-2 em linhagens ...